Want to join the conversation?
$BIIB said it is preparing to launch Zinbryta in Aug. 2016 in the US and Germany. Zinbryta is the first in a new class of multiple sclerosis therapy. The company added that Zinbryta will be used by patients switching for efficacy reasons, benefiting from once monthly at home subcutaneous administration and a differentiated mechanism of action.
$PYPL jumps 6% in after hours on strong results. I am bullish on this stock.
$TSCO stock remained active in the after hours trading and rose more than 2% after the retailer posted better than expected 1Q17 results.
Instagram has reached 700 million monthly active users. Looks like it will hit 1 billion soon. That would make it $FB’s fourth billion-user platform.